Skip to main content

Tecomet and Orchid Complete Transaction, Creating a Scaled Global Manufacturing Platform

Global medical manufacturing combination strengthens scale, technical capabilities, global footprint, and supply resilience to support OEM customers Woburn, MA, and Mason, MI, May 14, 2026 (GLOBE NEWSWIRE) — Tecomet and Orchid Orthopedic Solutions (“Orchid”) today announced the successful closing of their merger, forming a scaled global manufacturing partner serving MedTech and Aerospace & Defense customers. The combined company will operate under the Tecomet name. Tecomet will offer expanded capabilities across precision machining, additive manufacturing, forging, casting, and advanced finishing, supported by a more integrated and innovation-focused global manufacturing platform. This combination positions Tecomet to support customers across the product lifecycle from product development through full-scale production with...

Continue reading

Northwest Pump Expands California Presence with Acquisition of Total Petroleum Services

Strengthens service footprint and customer support across California PORTLAND, Ore., May 14, 2026 (GLOBE NEWSWIRE) — Northwest Pump & Equipment Co. (Northwest Pump), a leading provider of petroleum, industrial, and service solutions, today announced the acquisition of Total Petroleum Services (TPS), a respected provider of petroleum service and maintenance solutions based in California. The acquisition strengthens Northwest Pump’s existing presence in California and expands its ability to serve customers with enhanced service coverage, technical expertise, and integrated solutions across the state. “Total Petroleum Services has built a strong reputation for responsive service and deep customer relationships. That service-first mindset aligns directly with how we support our customers every day,” said Bob Mathews, President...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 13 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 13 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Rubicon Point Partners Acquires Shockwave Medical Headquarters Campus in Santa Clara, California

SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) — Rubicon Point Partners (“RPP”) announces the acquisition of the Shockwave Medical headquarters, a 201,078-square-foot, four-building R&D campus in Santa Clara, California, on behalf of Rubicon Point Fund II. The property is 100% NNN leased to Shockwave Medical, Inc., a medical device company and wholly owned subsidiary of Johnson & Johnson (S&P: AAA).   “This is the beginning of a billion dollar investment strategy that we plan to deploy over the coming few years throughout the region. This acquisition represents the quality and caliber of assets we will continue to target:  mission-critical real estate leased to world-class tenants in the most dynamic markets on the West Coast,” said Ani Vartanian, Co-Founder and Managing Partner of Rubicon Point Partners. Located...

Continue reading

Sumitomo Forestry Completes Acquisition of Tri Pointe Homes, Creating a Leading U.S. Homebuilder

Supports expansion of U.S. housing supply while accelerating growth of Tri Pointe Homes’ high-quality operations TOKYO and INCLINE VILLAGE, Nev., May 14, 2026 (GLOBE NEWSWIRE) — Sumitomo Forestry Co., Ltd. (“Sumitomo Forestry”) (TSE: 1911) and Tri Pointe Homes, Inc. (“Tri Pointe Homes”) today announced the successful completion of Sumitomo Forestry’s acquisition of Tri Pointe Homes for US$47.00 per share. With the closing of the transaction, Tri Pointe Homes is now a wholly owned subsidiary of Sumitomo Forestry America, Inc., which is a wholly owned subsidiary of Sumitomo Forestry Group, and will cease trading on the New York Stock Exchange. Through this acquisition, Tri Pointe Homes’ premium lifestyle brand, more than 160 active communities, and operations across 13 high-growth states will be added, making the Sumitomo Forestry...

Continue reading

Biogen Completes Acquisition of Apellis Pharmaceuticals

CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, complement-driven diseases, is now a wholly owned subsidiary of Biogen. The acquisition adds two best-in-class commercialized products, EMPAVELI® and SYFOVRE®, significantly bolstering Biogen’s near-term growth outlook and accelerating the Company’s expansion into nephrology. Together, the products recorded $689 million in net product revenue in 2025. This transaction will strengthen Biogen’s revenue and EPS growth potential by being accretive to Biogen’s Non-GAAP diluted EPS in 2027 and is expected to materially increase Biogen’s non-GAAP EPS compound annual growth rate (CAGR) through the...

Continue reading

Billion-Dollar AI deal, $100m in Acquisitions, $25m Founder Buy-In – Diginex Details Expansion Push

The Company has no debt, has completed more than US$100 million in M&A, signed a US$40 million strategic reseller agreement and had US$25.4 million in cash investment injected at share price levels ~4.7x higher than current since January 2025 Nasdaq IPO LONDON, May 14, 2026 (GLOBE NEWSWIRE) — Diginex Limited (Nasdaq: DGNX) (“Diginex” or the “Company”), a leading provider of Sustainability RegTech solutions, today provided an update on its previously announced acquisition of Resulticks Global Companies Pte Limited (Resulticks) along with the broader corporate transformation Diginex has executed since its Nasdaq listing in January 2025. Diginex and Resulticks have mutually agreed to extend the Long Stop date for Closing of the proposed transaction to May 29, 2026, as both parties work on the remaining closing condition workstreams....

Continue reading

Form 8.3 – Cordel Group Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Cordel Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Intuitive Machines to Acquire Goonhilly Earth Station and COMSAT

Expected to expand Intuitive Machine’s integrated space-to-Earth network, increasing capacity for deep space communications, data relay, and Position Navigation and Timing (PNT) capabilities  Expected to significantly boost infrastructure by adding 44 antennas, increasing network availability, and scaling spacecraft communication and control capabilities in lunar and cislunar environments HOUSTON, May 14, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space technology, infrastructure, and services leader, today announced it has entered into a definitive agreement to acquire Goonhilly Earth Station Ltd (“Goonhilly”), a world-class deep space communications provider with major ground station assets in the United Kingdom and Goonhilly USA Inc....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.